Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy.
Open Access
- 1 November 1995
- journal article
- clinical trial
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 96 (5), 2162-2169
- https://doi.org/10.1172/jci118270
Abstract
Studies conducted over the last decade demonstrated variable therapeutic efficacy of angiotensin converting enzyme (ACE) inhibitor on the progression of glomerular diseases, including IgA nephropathy. In this study, among patients with biopsy-proven IgA nephropathy, 53 patients in whom creatinine clearance had been monitored over 5 yr were recruited for study. These patients were classified into two groups according to whether or not renal function had declined as determined by the slope of creatinine clearance against time: group 1 had stable renal function; group 2 had declining renal function (average: -6.7 +/- 1.3 ml/min/yr). 21 of 53 patients were treated with ACE inhibitor and followed for 48 wk. Gene polymorphism consisting of insertion (I) or deletion (D) of a 287-bp DNA fragment (presumed to be a silencer element) of the ACE gene was determined by PCR. 46 age-matched individuals without history of proteinuria were analyzed as controls. The DD genotype was significantly more frequent in group 2 (43%) than in controls (7%) or group 1 patients with stable renal function (16%). 48 wk after ACE inhibitor administration, proteinuria significantly decreased in patients with DD genotype but not in those with ID or II genotypes. The results indicate that deletion polymorphism in the ACE gene, particularly the homozygote DD, is a risk factor for progression to chronic renal failure in IgA nephropathy. Moreover, this deletion polymorphism predicts the therapeutic efficacy of ACE inhibition on proteinuria and, potentially, on progressive deterioration of renal function.Keywords
This publication has 43 references indexed in Scilit:
- Association between a Deletion Polymorphism of the Angiotensin-Converting-Enzyme Gene and Left Ventricular HypertrophyThe New England Journal of Medicine, 1994
- Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring StudyJournal of Hypertension, 1993
- Association Analysis of a Polymorphism of the Angiotensin Converting Enzyme Gene with Essential Hypertension in the Japanese PopulationBiochemical and Biophysical Research Communications, 1993
- Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failureKidney International, 1992
- Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertensionBiochemical and Biophysical Research Communications, 1992
- IMephrotic-Range Proteinuria in a Patient with High Renin Hypertension: Effect of Treatment with an ACE-lnhibitorAmerican Journal of Nephrology, 1992
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.JCI Insight, 1990
- IgA Nephropathy in Japanese Children and Adults: A Comparative Study of Clinicopathological FeaturesAmerican Journal of Nephrology, 1990
- The Progression of Renal DiseaseThe New England Journal of Medicine, 1988
- The role of the tubulointerstitial changes in the prognosis of IgA glomerulonephritisJournal of Molecular Medicine, 1984